CHRISTINE ROSE MIGUEL: Open Payments
NPI 1972387900 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,281 in 171 payments from 18 companies in 2025. Trend: 2023 $20 · 2024 $2,742 · 2025 $4,281
Food & beverage: $4,281
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $774 |
| UCB, Inc. | 26 | $724 |
| Amgen Inc. | 24 | $579 |
| ANI Pharmaceuticals, Inc. | 13 | $407 |
| GlaxoSmithKline, LLC. | 14 | $258 |
| Mallinckrodt Hospital Products Inc. | 7 | $233 |
| E.R. Squibb & Sons, L.L.C. | 18 | $221 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $148 |
| KYOWA KIRIN, INC. | 3 | $146 |
| Radius Health, Inc. | 7 | $141 |
Products named: Bimzelx, OTEZLA, RINVOQ, PURIFIED CORTROPHIN GEL, BENLYSTA, ACTHAR, ORENCIA, SKYRIZI.
Industry payments across NV — which companies pay providers there.
